The National Agency for Food and Drug Administration and Control has announced the immediate ban on the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
In a public statement released on its website on Monday, NAFDAC cited the instability in its reconstituted form that compromises its effectiveness over time for the ban, saying that the decision affects both locally manufactured and imported…
Read the full article here
